10 Recruiting Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by Study Phase
Top Interventions for Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Related Conditions
Top Recruiting Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Studies
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck
📍 Moffitt Cancer Center-International Plaza — Tampa, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 / Phase3 💊 Investigational Drug / Biologic
Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
📍 Emory University Hospital Midtown — Atlanta, Georgia
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
📍 Emory University Hospital Midtown — Atlanta, Georgia
View Study & Checklist ➔ 🟢 Recruiting Observational / Diagnostic 🩺 Clinical Procedure Protocol
Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
📍 Emory Midtown University Hospital/Winship Cancer Institute — Atlanta, Georgia
View Study & Checklist ➔